Ben Richardson, CEO at SulNOx, confident they can cost-effectively decarbonise commercial shipping. Watch the video here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksJudges Scientific Regulatory News (JDG)

Share Price Information for Judges Scientific (JDG)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 11,200.00
Bid: 11,100.00
Ask: 11,200.00
Change: 0.00 (0.00%)
Spread: 100.00 (0.901%)
Open: 0.00
High: 0.00
Low: 0.00
Prev. Close: 11,200.00
JDG Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Acquisition of Korvus Technology Ltd

19 Oct 2020 07:00

RNS Number : 4005C
Judges Scientific PLC
19 October 2020
 

 

 

Press Release

19 October 2020

 

Judges Scientific plc

 

("Judges Scientific", "Judges", the "Company" or the "Group")

 

Acquisition of Korvus Technology Ltd

 

Judges Scientific, the group focused on acquiring and developing companies in the scientific instrument sector, announces it has acquired the entire issued share capital of Korvus Technology Limited ("Korvus" or the "Acquisition"), a maker of vapour deposition systems. The Board expects the Acquisition to be immediately earnings enhancing. 

 

The initial consideration for Korvus is £2.64 million in cash. The consideration for the Acquisition has been financed from the Group's £35 million acquisition facility from Lloyds Bank Corporate Markets.

 

Information and rationale for the Acquisition

 

Korvus specialises in the design and manufacture of vapour deposition systems used to coat materials with thin films. Korvus' systems are used for academic and industrial research, the majority of sales being to universities. Korvus' systems are particularly versatile with their modular hexagonal design, enabling the users to easily create a combination of accessories to meet their research requirements.

 

Korvus, based in Tavistock, Devon, was established in 2015 by Dr Lars and Philippa Allers; they will continue in their current roles until March 2021. From April 2021 to March 2025, Dr Allers will act for Korvus as a consultant, predominantly to help with new product development and strategy.

 

Korvus' statutory accounts for the financial year to 31 March 2020 show revenues of £1.42 million and pre-tax profits of £0.74 million. Net tangible assets amounted to £0.68 million, including cash of £0.16 million. Korvus' operating profit for the year ended 31 March 2020, adjusted to eliminate non-recurring items and to reflect Korvus' ongoing cost base within Judges, would have totalled £0.66 million. 

 

The Acquisition will add to the Group's capability in thin films alongside Quorum and Moorfield.

 

Terms of the Acquisition

 

The purchase price of Korvus consists of the following:

· The initial consideration, paid in cash at completion, amounts to £2.64 million;

· Deferred consideration of up to £0.4 million ("Earn-out Consideration") to be satisfied in cash.

 

The level of Earn-out Consideration payable will be based on Korvus' adjusted EBIT in the year to 31 March 2021.

 

An additional payment will be made to reflect any excess cash balances over and above the ongoing requirements of the business. The Board expects such payment to be covered by the cash inherited at the completion date.

Alex Hambro, Chairman of Judges, said:

"Korvus is an excellent company with innovative products, which will complement Judges' already strong capabilities in the coating sector, and we are looking forward to working with Phillipa and Lars towards a smooth transition. This cash generative acquisition, which is the third in the past eleven months, will enhance our earnings in accordance with our disciplined acquisition strategy and further demonstrates the resilience of our buy and build model."

 

For further information please contact:

Judges Scientific

 

 

David Cicurel, CEO

Brad Ormsby, Group FD

Tel: +44 (0) 20 3829 6970

 

 

Shore Capital (Nominated Adviser & Joint Broker)

 

Stephane Auton

Edward Mansfield

Sarah Mather

Tel: +44 (0) 20 7408 4090

 

 

 

Liberum (Joint Broker)

 

Bidhi Bhoma

Euan Brown

 

 

 

Tel: +44 (0) 20 3100 2222

 

Media enquiries:

Alma PR (Financial Public Relations)

 

Rebecca Sanders-Hewett

Sam Modlin

 

Tel: +44 (0) 20 3865 4219

judges@almapr.co.uk

 

Notes to editors:

Judges Scientific plc (AIM: JDG), is a group focused on acquiring and developing companies in the scientific instrument sector. The Group now consists of 19 businesses acquired since it was re-admitted to AIM in 2005.

The acquired companies are primarily UK-based with products sold worldwide to a diverse range of markets including: higher education institutions, the scientific communities, manufacturers and regulatory authorities. The UK is a recognised centre of excellence for scientific instruments. The Group companies hold five Queen's Awards for innovation and export. 

The Group's companies predominantly operate in global niche markets, with long term growth fundamentals and resilient margins.

Judges Scientific maintains a policy of selectively acquiring businesses that generate sustainable profits and cash. Shareholder returns are created through the repayment of debt, organic growth and dividends. 

For further information, please visit www.judges.uk.com

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
ACQBRBDGXGBDGGI
Date   Source Headline
31st Dec 20207:00 amRNSTotal Voting Rights
10th Dec 20207:00 amRNSDirector/PDMR Shareholding
16th Nov 20207:00 amRNSBlock listing Interim Review
12th Nov 20207:00 amRNSCORRECTION: Director/PDMR Shareholding
11th Nov 20204:48 pmRNSDirector/PDMR Shareholding
10th Nov 20207:00 amRNSDirector/PDMR Shareholding
3rd Nov 20207:00 amRNSGrant of Options
26th Oct 20205:16 pmRNSExercise of Options and Director Dealing
19th Oct 20204:38 pmRNSDirector/PDMR Shareholding
19th Oct 20207:00 amRNSAcquisition of Korvus Technology Ltd
7th Oct 20209:33 amRNSDirector/PDMR Shareholding
22nd Sep 20207:00 amRNSInterim Results
16th Sep 20202:17 pmRNSHolding(s) in Company
10th Sep 202011:25 amRNSDirector/PDMR Shareholding
10th Sep 20207:00 amRNSBoard Change
1st Sep 20209:48 amRNSTotal Voting Rights
11th Aug 20208:24 amRNSDirector/PDMR Shareholding
31st Jul 20207:00 amRNSTotal Voting Rights
21st Jul 20207:00 amRNSTrading Update and Notice of Interim Results
7th Jul 20202:28 pmRNSDirector/PDMR Shareholding
30th Jun 20207:00 amRNSTotal Voting Rights
8th Jun 20204:03 pmRNSDirector/PDMR Shareholding
2nd Jun 20207:00 amRNSTotal Voting Rights
29th May 20207:00 amRNSAcquisition of Heath Scientific Company Limited
20th May 20201:55 pmRNSResult of AGM
20th May 20207:00 amRNSAGM Update
15th May 20208:53 amRNSBlock listing Interim Review
14th May 20209:52 amRNSAGM Q&A
7th May 20209:59 amRNSDirector/PDMR Shareholding
30th Apr 20209:52 amRNSTotal Voting Rights
28th Apr 20207:00 amRNSNotice of AGM
8th Apr 202010:23 amRNSDirector/PDMR Shareholding
31st Mar 202011:10 amRNSTotal Voting Rights
18th Mar 20207:00 amRNSFinal Results
17th Mar 202011:05 amRNSSecond Price Monitoring Extn
17th Mar 202011:00 amRNSPrice Monitoring Extension
10th Mar 20208:55 amRNSDirector/PDMR Shareholding
24th Feb 20207:00 amRNSStatement regarding COVID-19
7th Feb 20207:00 amRNSDirector/PDMR Shareholding
31st Jan 202010:46 amRNSBlocklisting Application and Total Voting Rights
16th Jan 20203:18 pmRNSExercise of Options and Director Dealing
16th Jan 20207:00 amRNSTrading Statement and Notice of Final Results
13th Jan 20209:37 amRNSDirector/PDMR Shareholding
2nd Jan 20201:42 pmRNSTotal Voting Rights
18th Dec 20198:49 amRNSHolding(s) in Company
6th Dec 20193:01 pmRNSDirector/PDMR Shareholding
6th Dec 20192:40 pmRNSDirector/PDMR Shareholding
4th Dec 20197:00 amRNSAcquisition of Moorfield Nanotechnology Limited
21st Nov 20197:00 amRNSSpecial dividend
15th Nov 20197:00 amRNSBlocklisting Return

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.